Marijuana Investor Roundup: Analysis of the Week’s Most Important Events (October 21, 2018)

Scott Willis·October 21, 2018

The power of a U.S. listing explained. Aphria to list on the NYSE. Demand looks to have peaked...

Aphria to List on NYSE – Pathway to Meaningful Upside Triggered

Scott Willis·October 18, 2018

US-listed cannabis stocks trade at big premiums to Canadian peers. Inside we list 4 compelling reasons why Aphria...

Scott Willis·October 16, 2018

This report explores the powerful upside that a dual US/CDN listing provides. Our top four cannabis stocks to...

Martin Green·October 16, 2018

German firm Cannamedical Pharma has filed a claim for damages against Aurora Cannabis after accusing it of breaching...

Scott Willis·October 12, 2018

A transitional quarter that underscores Aphria's cost leadership within the industry. The company will produce more cannabis than...

Editor·October 6, 2018

Coke needs cannabis more than cannabis needs Coke, CannTrust only weeks away from announcing a deal, CBD from...

Scott Willis·September 30, 2018

Marijuana Weekly Roundup: Deep dive into the potential of CBD; review of Aurora's earnings; Ontario only allowing 1...

Scott Willis·September 25, 2018

Aurora Cannabis (TSE: ACB) is still one of the top acquisition targets for a cannabis acquirer and earnings...

Scott Willis·September 24, 2018

Exploring the Cannabidiol CBD market potential and the three best stocks to own to play this new high...

Username
Password

	Remember Me Lost your password?